Is surveillance imaging in pediatric patients treated for localized rhabdomyosarcoma useful? The European experience.

ABSTRACT:

Background

After the completion of therapy, patients with localized rhabdomyosarcoma (RMS) are subjected to intensive radiological tumor surveillance. However, the clinical benefit of this surveillance is unclear. This study retrospectively analyzed the value of off-therapy surveillance by comparing the survival of patients in whom relapse was detected by routine imaging (the imaging group) and patients in whom relapse was first suspected by symptoms (the symptom group).

Methods

This study included patients with relapsed RMS after the completion of therapy for localized RMS who were treated in large pediatric oncology hospitals in France, the United Kingdom, Italy, and the Netherlands and who were enrolled in the International Society of Paediatric Oncology Malignant Mesench

SUBMITTER: Vaarwerk B 

PROVIDER: S-EPMC7027831 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature